Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.
about
Teicoplanin-induced neutropenia in a paediatric patient with vertebral osteomyelitis.Regional prophylaxis with teicoplanin in monolateral or bilateral total knee replacement: an open studyComparison of antimicrobial agents as therapy for experimental endocarditis: caused by methicillin-resistant Staphylococcus aureus.Antimicrobial activity of MDL 63,246, a new semisynthetic glycopeptide antibiotic.Successful single-dose teicoplanin prophylaxis against experimental streptococcal, enterococcal, and staphylococcal aortic valve endocarditis.Activity of vancomycin, teicoplanin and cephalosporins against penicillin-susceptible and penicillin-intermediate Streptococcus pneumoniae.Regional and systemic prophylaxis with teicoplanin in monolateral and bilateral total knee replacement procedures: study of pharmacokinetics and tissue penetrationVascular graft infection by Staphylococcus aureus: efficacy of linezolid, teicoplanin and vancomycin systemic prophylaxis protocols in a rat modelEffect of teicoplanin on the expression of c-myc and c-fos proto-oncogenes in MCF-7 breast cancer cell line.Binding of teicoplanin and vancomycin to bovine serum albumin in vitro: a multispectroscopic approach and molecular modeling.Which prosthesis is more resistant to vascular graft infection: polytetrafluoroethylene or Omniflow II biosynthetic grafts?A closer look at vancomycin, teicoplanin, and antimicrobial resistance.In vitro evaluation of BI 397, a novel glycopeptide antimicrobial agent.Combined therapy of teicoplanin and caffeic acid phenethyl ester (CAPE) in the treatment of experimental mediastinitis in the rat.Experience with teicoplanin in the treatment of neonatal staphylococcal sepsis.Efficacy of teicoplanin, administered in two different regimens, in the treatment of experimental endocarditis due to Enterococcus faecalis.Antimicrobial spectrum and potency of dalbavancin tested against clinical isolates from Europe and North America (2003): initial results from an international surveillance protocol.Teicoplanin with other drugs: possible pharmacological interactions.
P2860
Q32101290-E0C33733-DE05-4A29-A6E0-5E07E2C76DC6Q33978696-DC8B2977-3A9E-4238-83CC-87D973AFB1BEQ34090666-2E6C0CAF-1B54-438D-ADB9-A16F6411BE06Q35116375-2C8A8A48-C206-42F6-99D0-5F26DDC67726Q35138023-1FE9C780-A90E-4C4A-BB82-AAA139C4E879Q35816735-560B90EB-3464-4BAB-8605-09A230F8CE4CQ35904557-F34ABDB6-EE4F-4FF3-AA55-10F4D08CAF41Q37041345-B1AA84CC-1810-48CB-AA2C-1FFB450B4857Q38724038-AD87804E-FD88-4F19-8678-563CD924C4E2Q39432002-044EAE71-5633-46C7-ACC3-65C74350B293Q41446911-462CBAF0-8E02-4703-B448-9D84169FDD59Q41646436-835EFBC2-C74D-4F10-B881-849B6E442095Q43672054-C32BE4B7-5FD8-40FE-B90A-F56DC2713FE2Q44406594-5D4120C2-402C-4370-A32D-1894C2BCBBAAQ45085713-8E85882D-5EB1-4698-AA30-256C674C34A8Q45158747-E713BFE8-26D8-47A0-AAA1-AAD9BA9E50B9Q46908676-A8C7F189-D4F2-42A6-A308-A0CCAF774BBEQ54248052-00501A21-0DAA-49BD-AAE4-2F95504389AB
P2860
Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Teicoplanin. A review of its a ...... ies and therapeutic potential.
@en
Teicoplanin. A review of its a ...... ies and therapeutic potential.
@nl
type
label
Teicoplanin. A review of its a ...... ies and therapeutic potential.
@en
Teicoplanin. A review of its a ...... ies and therapeutic potential.
@nl
prefLabel
Teicoplanin. A review of its a ...... ies and therapeutic potential.
@en
Teicoplanin. A review of its a ...... ies and therapeutic potential.
@nl
P1433
P1476
Teicoplanin. A review of its a ...... ies and therapeutic potential.
@en
P2093
Campoli-Richards DM
P304
P356
10.2165/00003495-199040030-00007
P577
1990-09-01T00:00:00Z